DVAX: Nilai perusahaan marang bathi resik dynavax.com

Simbol lan logo merek Dynavax Pharma (DVAX)

Dynavax Technologies (DVAX) supplies proven hepatitis vaccines, ensuring stable sales through its patents. However, geopolitical conflicts could disrupt raw material supplies and complicate international certification. Revenues are based on hepatitis B drugs and the success of new R&D developments. The company's weighted average P/E reflects the dynamics of return on capital, where the value -41.50 describes the current level of market valuation.

DVAX - Pangali P/E Dynavax Technologies Corp ing rentang 04.07.2022 - 21.02.2026

Rincian metrik komprehensif lan analitis Dynavax Technologies (DVAX)

- rega lan prakiraan konsensus rega:
Rega saham Dynavax Corp|DVAX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Dynavax Technologies Corporation|DVAX - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham Dynavax|DVAX - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku dynavax.com|DVAX - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Dynavax Technologies|DVAX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal dynavax.com|DVAX - Utang perusahaan|Rasio utang marang aset resik Dynavax Technologies Corporation|DVAX - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Dynavax|Likuiditas darurat dynavax.com
- statistik bathi lan rasio pasar:
DVAX - Bathi resik perusahaan|Prakiraan bathi resik Dynavax Technologies|DVAX - Pangali P/E|Pangali Forward P/E Dynavax Technologies Corp|DVAX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Dynavax Technologies Corporation|DVAX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Dynavax|DVAX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan dynavax.com|DVAX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Dynavax Technologies
- statistik dodolan lan pendapatan perusahaan:
DVAX - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan Dynavax Technologies|DVAX - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Dynavax Technologies Corporation
Analisis komprehensif perusahaan:Dynavax Technologies Corporation - DVAX
Produk merek Dynavax Technologies Corp

The P/E ratio compares the current market value of a business to its net income, determining the actual cost of each dollar of earnings. By analyzing the P/E history of Dynavax Technologies (DVAX), an investor can identify asset overvaluation or hidden risks, which is critical for Dynavax Technologies (DVAX) due to its reliance on a single drug and the need for large-scale R&D investments to diversify its portfolio.

Pesaing wigati

Pangali P/E arrowheadpharma.com|Koefisien rega marang bathi MIRM (Mirum)|ABUS (Arbutus Biopharma Corp) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Inventiva Pharma IVA|Gyre Therapeutics Corp. - Rasio rega marang bathi|Assembly Biosciences - Pangali P/E|Periode bali modal bisnis Galectin Therapeutics GALT|GNFT (genfit.com) - Koefisien rega marang bathi|DRRX (DURECT) - Rasio rega marang bathi|ALGS (Aligos Therapeutics Inc.) - Pangali P/E|Kapitalisasi marang bathi BioVie Pharma BIVI|Rasio rega marang bathi Galmed Pharmaceuticals (GLMD)|NDRA (endrainc.com) - Nilai perusahaan marang bathi resik|Pangali P/E HEPA (Hepion Pharmaceuticals, Inc.)